Organogenesis Holdings (ORGO) Free Cash Flow (2016 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Free Cash Flow of $18.0 million for Q1 2026, up 176.32% year-over-year from $6.5 million in Q1 2025, and down 48.28% quarter-over-quarter from $34.8 million in Q4 2025.
Organogenesis Holdings (ORGO) Free Cash Flow (2016 - 2026) Analysis & Trends
Organogenesis Holdings' Free Cash Flow history runs 11 years deep, the most recent figure standing at $18.0 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 176.32% year-over-year to $18.0 million; the TTM figure through Mar 2026 stood at $17.1 million (up 302.47% YoY), while the FY2025 annual figure was -$24.5 million, down 685.73% from the prior year.
- Free Cash Flow for Q1 2026 stood at $18.0 million, down from $34.8 million in the prior quarter.
- The five-year high for Free Cash Flow was $34.8 million in Q4 2025, with the low at -$36.5 million in Q2 2025.
- The 5-year median for Free Cash Flow is -$458000.0 (2022), against an average of -$281705.9.
- The sharpest annual moves came in 2023 and 2025: Free Cash Flow jumped 1227.58% in 2023, then slumped 2667.58% in 2025.
- Organogenesis Holdings' Free Cash Flow stood at -$2.9 million in 2022, then jumped by 355.25% to $7.3 million in 2023, then advanced by 3.92% to $7.6 million in 2024, then jumped by 358.92% to $34.8 million in 2025, then tumbled by 48.28% to $18.0 million in 2026.
- Business Quant data shows ORGO's Free Cash Flow at $18.0 million in Q1 2026, $34.8 million in Q4 2025, and $844000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | -32.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -32.75 Mn |
| Jun 30, 2026 | -32.75 Mn |
| Mar 31, 2026 | 17.98 Mn |
| Mar 31, 2026 | 17.98 Mn |
| Dec 31, 2025 | 34.77 Mn |
| Dec 31, 2025 | 34.77 Mn |
| Sep 30, 2025 | 844,000.00 |
| Sep 30, 2025 | 844,000.00 |
| Jun 30, 2025 | -36.51 Mn |
| Jun 30, 2025 | -36.51 Mn |
| Mar 31, 2025 | -23.56 Mn |
| Mar 31, 2025 | -23.56 Mn |
| Dec 31, 2024 | 7.58 Mn |
| Dec 31, 2024 | 7.58 Mn |
| Sep 30, 2024 | 6.13 Mn |
| Sep 30, 2024 | 6.13 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Mar 31, 2024 | -10.95 Mn |
| Mar 31, 2024 | -10.95 Mn |